Transition to new antiretroviral drugs in HIV programmes: Clinical and programmatic considerations

M. Doherty; M. Vitoria; M. Penazzato; et al. World Health Organization (2017) C_WHO

The document is not on the server. This browser does not support external PDFs as inline view . Please download the PDF to view it: Download PDF